EXOME

all the information, none of the junk | biotech • healthcare • life sciences

CMC Icos to Make Lung Drug

CMC Icos Biologics, the Bothell, WA-based contract manufacturer of biotech drugs, said today it has signed a deal to manufacture an experimental drug for acute lung injury. CMC will make IC14, an antibody drug, for Brisbane, Australia-based Implicit Bioscience. The treatment, which is scheduled to enter Phase II trials next year, was previously tested in 150 patients by Icos for its potential against inflammatory diseases.